Association between BNP levels and new-onset atrial fibrillation: A propensity score approach
View/ Open
Access
info:eu-repo/semantics/embargoedAccessDate
2018Author
Karabaǧ, YavuzRencüzoğulları, İbrahim
Çaǧdaş, Metin
Karakoyun, Süleyman
Yesin, Mahmut
Uluganyan, Mahmud
Gürsoy, Mustafa Ozan
Artaç, İnanç
İliş, Doǧan
Gökdeniz, Tayyar
Efe, Süleyman Çağan
Taşar, Onur
Tanboǧa, Halil İbrahim
Metadata
Show full item recordCitation
Karabaǧ, Y., Rencüzoğulları, İ., Çaǧdaş, M., Karakoyun, S., Yesin, M., Uluganyan, M. ... Tanboǧa, H. (2018). Association between BNP levels and new-onset atrial fibrillation: A propensity score approach. Herz, 43(6), 548-554. https://dx.doi.org/10.1007/s00059-017-4598-6Abstract
New-onset atrial fibrillation (NOAF), a common complication of acute ST-segment elevation myocardial infarction (STEMI), is associated with a poor prognosis. Several clinical and laboratory parameters are reported to be associated with NOAF in patients with STEMI. The aim of the present study was to evaluate the predictive value of plasma BaEurotype natriuretic peptide (BNP) levels for NOAF development and long-term prognosis in STEMI patients undergoing primary percutaneous coronary intervention (pPCI). We retrospectively enrolled 1,928 patients with STEMI who underwent pPCI. After applying exclusion criteria, 1,057 patients were retained in the final study population. Patients with NOAF were compared with patients without NOAF in the entire study population and in a matched group. Patients with NOAF had a significantly higher average plasma BNP level (161 pg/ml, range: 72.3-432) than patients without NOAF in the study population (70.7 pg/ml, range: 70-129; p <0.001) and in the matched group (104.6 pg/ml, range: 47.2-234.5; p = 0.014). Furthermore, the plasma BNP level was found to be an independent predictor of NOAF development (odds ratio [OR]: 1.003; 95% confidence interval [CI]: 1.000-1.005; p = 0.034) and mortality in the long-term follow-up (OR: 1.004; 95% CI: 1.002-1.006; p <0.001). The present study found that a high plasma BNP level was significantly associated with NOAF development in STEMI patients, and was an independent predictor of NOAF development and all-cause mortality during long-term follow-up, regardless of other NOAF risk factors.
WoS Q Kategorisi
Q4xmlui.dri2xhtml.METS-1.0.item-scopusquality
Q3Source
HerzVolume
43Issue
6Collections
- Makale Koleksiyonu [3650]
- PubMed İndeksli Yayınlar Koleksiyonu [4048]
- Scopus İndeksli Yayınlar Koleksiyonu [6284]
- WoS İndeksli Yayınlar Koleksiyonu [6432]